JP2024536479A5 - - Google Patents
Info
- Publication number
- JP2024536479A5 JP2024536479A5 JP2024522027A JP2024522027A JP2024536479A5 JP 2024536479 A5 JP2024536479 A5 JP 2024536479A5 JP 2024522027 A JP2024522027 A JP 2024522027A JP 2024522027 A JP2024522027 A JP 2024522027A JP 2024536479 A5 JP2024536479 A5 JP 2024536479A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- cells
- approximately
- egfr
- kidney
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255885P | 2021-10-14 | 2021-10-14 | |
| US63/255,885 | 2021-10-14 | ||
| US202263307801P | 2022-02-08 | 2022-02-08 | |
| US63/307,801 | 2022-02-08 | ||
| US202263321204P | 2022-03-18 | 2022-03-18 | |
| US63/321,204 | 2022-03-18 | ||
| PCT/US2022/078153 WO2023064925A1 (en) | 2021-10-14 | 2022-10-14 | Treatment of kidney disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536479A JP2024536479A (ja) | 2024-10-04 |
| JP2024536479A5 true JP2024536479A5 (https=) | 2025-10-15 |
Family
ID=85988933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522027A Pending JP2024536479A (ja) | 2021-10-14 | 2022-10-14 | 腎臓疾患の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250009803A1 (https=) |
| EP (1) | EP4415729A4 (https=) |
| JP (1) | JP2024536479A (https=) |
| KR (1) | KR20240110801A (https=) |
| AU (1) | AU2022362077A1 (https=) |
| CA (1) | CA3233866A1 (https=) |
| MX (1) | MX2024004355A (https=) |
| WO (1) | WO2023064925A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106530A1 (en) * | 2023-11-13 | 2025-05-22 | Butler Emily | Characteristics of enriched heterogeneous renal cell populations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020266168A1 (en) * | 2019-05-02 | 2021-12-02 | ProKidney IPCo, LLC | Treatment of kidney disease in subjects with kidney and/or urinary tract anomalies |
-
2022
- 2022-10-14 AU AU2022362077A patent/AU2022362077A1/en active Pending
- 2022-10-14 US US18/699,849 patent/US20250009803A1/en active Pending
- 2022-10-14 CA CA3233866A patent/CA3233866A1/en active Pending
- 2022-10-14 JP JP2024522027A patent/JP2024536479A/ja active Pending
- 2022-10-14 KR KR1020247015819A patent/KR20240110801A/ko active Pending
- 2022-10-14 MX MX2024004355A patent/MX2024004355A/es unknown
- 2022-10-14 WO PCT/US2022/078153 patent/WO2023064925A1/en not_active Ceased
- 2022-10-14 EP EP22882059.3A patent/EP4415729A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5105687B2 (ja) | 高活性および低減された副作用を有する組換えエリスロポエチンの治療的使用 | |
| Vehaskari et al. | The effects of polycations on vascular permeability in the rat. A proposed role for charge sites. | |
| TWI440457B (zh) | 含檸檬酸及/或檸檬酸鹽之組成物的用途 | |
| JP2019531357A5 (https=) | ||
| CN101310772B (zh) | 用于诱导神经发生的氧化氮供体 | |
| AU2010336475A1 (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| US20250064977A1 (en) | Nucleic Acid-Based Compositions and Methods for Treating Small Vessel Diseases | |
| CN110072531A (zh) | 用于治疗心血管相关疾病的爱帕琳的新型聚乙二醇化的脂质体制剂 | |
| JP2024536479A5 (https=) | ||
| JP2025020303A5 (https=) | ||
| Faltlhauser et al. | Use of hemoadsorption in a case of severe hepatic failure and hyperbilirubinemia | |
| DE60021360T2 (de) | Vegf angiogenische wachstumsfaktoren zur behandlung von peripherer neuropathie | |
| CA2516452A1 (en) | Estradiol metabolites for the treatment of pulmonary hypertension | |
| JP2004500437A (ja) | 可動化活性を有する調製物 | |
| Wang et al. | Hypoxic pulmonary hypertension (HPH) and iptakalim, a novel ATP‐sensitive potassium channel opener targeting smaller arteries in hypertension | |
| CN121443295A (zh) | 治疗前列腺癌的方法 | |
| JP5791064B2 (ja) | 医薬用組成物 | |
| Li et al. | The roller coaster of lamotrigine levels: Successful treatment of massive lamotrigine overdose with continuous veno-venous hemodiafiltration and rifampin | |
| Wellens et al. | Distribution of the blood flow supplied by the vertebral artery in rats: anatomical, functional and pharmacological aspects | |
| KR101303920B1 (ko) | 프로토포르피린 ＩＸ 구조를 갖는 화합물을 포함하는, 저산소상태 유도성인자1α 또는 혈관내피세포성장인자 과다 발현으로 기인하는 질병의 예방 및 치료에 유용한 조성물 | |
| JP6824287B2 (ja) | 自己免疫系の活性化におけるｚ−ブチリデンフタリドの使用 | |
| Soundararajan | American Heart Association (AHA) Scientific Sessions-2022 Annual Meeting. Chicago/Virtual-November 5-7, 2022 | |
| CN110747266A (zh) | miR-21和miR-21拮抗剂在抑制预防/治疗1型糖尿病中的应用 | |
| Hawthorne et al. | Antihypertensive effect of hypophysectomy in dogs with hypertension following bilateral carotid sinus constriction | |
| JP3570557B2 (ja) | ｒｅｇタンパク質を有効成分とする薬剤 |